SUNSHINE BIOPHARMA INC. (SBFM) Capital expenditures 2016–2025
SUNSHINE BIOPHARMA INC. (SBFM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$174,491FY2025 · since FY2016: $3,439 → $174,491
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $174,491 | -89.5% |
| FY2024 | $1.7M | +1914.6% |
| FY2023 | $82,251 | -57.6% |
| FY2022 | $193,982 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $1,191 | +38.5% |
| FY2019 | $860 | -95.4% |
| FY2018 | $18,850 | +407.0% |
| FY2017 | $3,718 | +8.1% |
| FY2016 | $3,439 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice